Skip to content
Screener

EV / EBITDA at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
24.5×-26.3×
UnitedHealth Group logo
UnitedHealth GroupUNH
16.3×+6.9×
Conduent Incorporated logo
Conduent IncorporatedCNDT
10.3×
Corvel logo
CorvelCRVL
16.1×-16.8×
Phreesia logo
PhreesiaPHR
17.3×
IQVIA logo
IQVIAIQV
13.8×+1.3×

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%
EPS (diluted)-$3.49+8.4%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Calculated from Claritev Corporation’s reported figures.

Based on the most recent quarter.

The source filing: Claritev Corporation’s 10-Q, filed August 7, 2026. Open the filing →

Filed
Aug 7, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001793229-26-000067

FAQ

What is Claritev Corporation's EV / EBITDA?
Claritev Corporation (CTEV) reported EV / EBITDA of 10.9× in Q2 2026.
How has Claritev Corporation's EV / EBITDA changed year-over-year?
Claritev Corporation's EV / EBITDA decreased by 82.0% year-over-year, from 60.9× to 10.9×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about Claritev Corporation's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude